简体
简体中文
繁體中文

CinCor Pharma, Inc. CINC

等待开盘 08-01 09:30:00 美东时间

29.06

0.000

0.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 0股
  • 最 低 --
  • 昨 收 29.06
  • 总市值 12.72亿
  • 52周最高 43.15
  • 市盈率 --
  • 换手率 0.00%
  • 52周最低 10.53
  • 委 比 0.00%
  • 总股本 4378.38万
  • 历史最高 43.15
  • 量 比 0
  • 振 幅 0.00%
  • 历史最低 10.53
  • 每 手 1
  • 风险率 0.07%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Kroger Announces New Leaders in Key Roles

    Ed Oldham to join retailer as Head of Sourcing Ann Reed Named Group Vice President of Our Brands Jake Cannon Named Cincinnati-Dayton Division President Josh Harpole Named Louisville Division...

    07-30 04:00

  • Kroger Crafts the Perfect Sandwich-Making Guide

    Retailer shares guide to creating sandwiches with endless possibilities in every bite CINCINNATI, July 29, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR), America's grocer, today shared a gu...

    07-29 22:15

  • Cincinnati Financial Reports Second-Quarter 2025 Results

    CINCINNATI, July 28, 2025 /PRNewswire/ -- Cincinnati Financial Corporation (Nasdaq: CINF) today reported: Second-quarter 2025 net income of $685 million, or $4.34 per share, compared with $3...

    07-29 04:05

  • Scripps announces proposed placement of senior notes

    CINCINNATI, July 28, 2025 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) has launched an offering of $650 million of new senior secured second-lien notes. The notes are expected to m...

    07-28 19:31

  • Get All the Tools for Back to School at Kroger

    Retailer debuts teacher-issued supply lists with one-click purchase, making back-to-school shopping for class and the lunchroom easier than ever; school supplies for as little as 39 cents CI...

    07-23 21:30

  • George Vincent Named as Kroger Secretary and General Counsel

    Retailer announces succession plan, welcomes experienced corporate lawyer CINCINNATI, July 22, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR) today announced George Vincent will join the com...

    07-23 02:45

  • 50亿大药+1,阿斯利康谋新章

    (来源:药剂Talks) 阿斯利康,又添一款重磅炸弹药物。 近日,阿斯利康全新机制降压药Baxdrostat的III期BaxHTN研究取得了积极结果,意味着开...

    07-21 17:07

  • Coming Soon: Boost Bonus Days

    More than $100 in grocery savings available to Boost by Kroger Plus members during the two-week event; for a limited time renew or enroll at 50% off CINCINNATI, July 14, 2025 /PRNewswire/ --...

    07-14 22:00

  • AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial

    AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a favorable safety profile.

    07-14 21:05

  • 阿斯利康高血压新药初战告捷,被寄予高度期待或改写治疗版图

    ①阿斯利康公司宣布,其实验性高血压药物Baxdrostat在临床试验中显著降低了难以控制或对治疗无反应型高血压患者的血压; ②阿斯利康预计在2026年将Baxdrostat推向市场,并认为该药物每年有望带来超过50亿美元的销售额。

    07-14 20:49